All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @_sav_23 on TikTok · 180s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @_sav_23's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So you heard about his epic.
  2. 0:02Maybe you wrote it or maybe you want to try it.
  3. 0:05Either or or and you just want some more information.
  4. 0:07Don't worry I got you.
  5. 0:08I've been on those epic for just about a year and I'm here to give you some information about it.
  6. 0:14I already had a part one come in an intro, part two talking about dosage.
  7. 0:19Now I'm going to kind of give a rundown about some do's and don'ts that I've experienced,
  8. 0:23some things that I've noticed that might help you along your journey and kind of go from there.
  9. 0:28Just a disclaimer, I'm not a doctor.
  10. 0:31I'm not a physician.
  11. 0:32I'm not anyone in the medical field.
  12. 0:34I'm just a random person that started this and experienced it and figured I'd share it.
  13. 0:40I started a little bit of a series because when I started in looking at this,
  14. 0:44I searched it, I searched online.
  15. 0:47I did my research and there was some very helpful videos out there that really gave me some more information about injection sites
  16. 0:54and just kind of just information in general that really helped me ease my mind
  17. 1:00because of course I knew medication always kind of makes us kind of free up a little bit.
  18. 1:05Number one thing I can tell you, drink your water.
  19. 1:09This medication, it absolutely dries you out from the inside out.
  20. 1:14Your skin's dry, your insides are dry and it just it just to hydrates you.
  21. 1:19If you do not get your amount of water that you need like two to three liters at least.
  22. 1:24And you'll be able to notice because actually a lot of people reported this because I talked to my doctor about it.
  23. 1:30The smell of your pee, it is potent as shit.
  24. 1:34Whenever you're dehydrated because your body goes help, it smells like industrial cleaner.
  25. 1:38It's not a fun time.
  26. 1:41So do your best to drink your water.
  27. 1:43Sometimes you do forget to eat because slosive GI tract down and naturally suppresses your appetite
  28. 1:50and your portions go down because you're just not thinking about food.
  29. 1:53So that's where the weight loss comes from.
  30. 1:55Don't do that.
  31. 1:56You need to eat to feel your body as not healthy to not eat at all.
  32. 2:01If you're prone to that, try investing in like protein shakes or you know snacks in the fridge.
  33. 2:07I love the core power protein shakes has 26 grams of protein in them.
  34. 2:12They're fantastic for on the go.
  35. 2:14Tastes like milkshakes.
  36. 2:15So I love those.
  37. 2:17Make sure you set an alarm for when your shot is due.
  38. 2:21And always try to put your alcohol swab on there just because sometimes you need a little cleaning.
  39. 2:27Also, don't use the same needle because the second time you put it in your body, it's dull and that's when you start to bruise.
  40. 2:33You think you want to like save needles because I know they're expensive but just don't.
  41. 2:37Just use a different one every time you'll have no problems, especially if you're afraid of needles and you're afraid of it's going to hurt.
  42. 2:43It doesn't hurt.
  43. 2:44But if you continue to use the same needle over and over again that does get dull and then it does hurt and it does bruise.
  44. 2:50Over the next couple of videos I'm going to start talking about my before and afters kind of where I am at now and anything else that you might want to know.

@_sav_23's Ozempic dos and don'ts: what she got right

Sav

TikTok creator

1.8M viewsWatch on TikTok

Quick answer

Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and affects central satiety signaling, leading to clinically significant weight loss in trials like STEP 1 (Wilding et al., 2021, NEJM). The creator's practical tips around hydration, adequate protein intake, and single-use needle hygiene are consistent with general clinical guidance for patients on injectable GLP-1 therapies. However, attributing dehydration to a direct drug mechanism rather than reduced intake and GI side effects is a common patient misconception that clinicians should address during counseling.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @_sav_23's Ozempic dos and don'ts: what she got right, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@_sav_23's Ozempic dos and don'ts: what she got right" from Sav. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and affects central satiety signaling, leading to clinically significant weight loss in trials like STEP 1 (Wilding et al.

The reason this review is not generic is the source wording and the canonical claim label "glp1 1 year ozempic experience part 3 dos and donts ozempic." In this clip, the useful excerpt is: "So you heard about his epic." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Pen needles are single-use medical devices.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and affects central satiety signaling, leading to clinically significant weight loss in trials like STEP 1 (Wilding et al.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and affects central satiety signaling, leading to clinically significant weight loss in trials like STEP 1 (Wilding et al., 2021, NEJM). The creator's practical tips around hydration, adequate protein intake, and single-use needle hygiene are consistent with general clinical guidance for patients on injectable GLP-1 therapies. However, attributing dehydration to a direct drug mechanism rather than reduced intake and GI side effects is a common patient misconception that clinicians should address during counseling.
  • Wilding et al. (2021, NEJM) found participants on semaglutide lost an average of 14.9% body weight over 68 weeks, with lean mass loss documented alongside fat loss.
  • Pen needles are single-use medical devices. Frid et al. (2016) confirmed reuse causes tip deformation that increases injection pain and local skin trauma.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Wilding et al. (2021, NEJM) found participants on semaglutide lost an average of 14.9% body weight over 68 weeks, with lean mass loss documented alongside fat loss.
  • Pen needles are single-use medical devices. Frid et al. (2016) confirmed reuse causes tip deformation that increases injection pain and local skin trauma.
  • Semaglutide does not pharmacologically pull water from tissues. Dehydration risk comes from lower food and fluid intake and GI side effects like nausea, not a direct drying mechanism.
  • Armstrong (2005, Nutrition Reviews) confirmed urine color and odor are reliable early markers of dehydration, supporting the creator's practical observation about strong-smelling urine.
  • Bikou et al. (2023, Nutrients) found resistance training combined with adequate protein intake during GLP-1 therapy helps preserve lean muscle mass that would otherwise be lost.
  • The American Diabetes Association has moved away from requiring alcohol swabbing before subcutaneous injections in home settings for patients with clean skin, though the practice is not harmful.
  • Ozempic (semaglutide 0.5-2mg) is FDA-approved for type 2 diabetes management. Wegovy (semaglutide 2.4mg) is approved for chronic weight management. Both require a licensed prescriber.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @_sav_23 actually say?

In her third Ozempic video, @_sav_23 offers a personal rundown of habits she says helped her through a year on semaglutide. Her main claims: the drug dehydrates you and you need "two to three liters" of water daily, you should not skip meals even when appetite disappears, you should set injection alarms, use an alcohol swab, and never reuse needles because "the second time you put it in your body, it's dull and that's when you start to bruise."

She is clear she is not a medical professional. She frames everything as personal experience, which is honest. But 1.8 million people are watching, so personal experience at that scale starts to function like health advice whether she intends it to or not. That matters.

Her tone is practical and her disclaimers are genuine. She is not selling anything in this clip. That earns her some credit going in.

Does the science back this up?

On hydration, she is largely correct. GLP-1 receptor agonists like semaglutide slow gastric emptying and reduce appetite, which can lead to lower fluid intake overall. Nausea-driven vomiting adds to fluid losses. The clinical literature on semaglutide does not specifically quantify a "two to three liter" daily target, but that range is consistent with general adult hydration guidelines from the National Academies of Sciences (2004). Her observation about concentrated, strong-smelling urine as a dehydration signal is accurate. Dark urine is a well-documented early indicator of hypohydration (Armstrong, 2005, Nutrition Reviews).

On muscle and protein preservation, the concern about skipping meals is well-supported. Wilding et al. (2021, NEJM) in the STEP 1 trial noted that semaglutide patients lost meaningful lean mass alongside fat. Eating adequate protein helps preserve that muscle. Her protein shake suggestion is practical, not harmful.

On needle reuse, the pharmacology is straightforward: pen needles are single-use by design. Reuse causes microscopic barb formation on the tip, increasing injection pain and tissue trauma. This is confirmed in device engineering literature and flagged in insulin pen needle guidelines (Frid et al., 2016, Diabetes Technology and Therapeutics).

What did they get wrong (or right)?

She got more right than wrong. The dehydration claim, the needle reuse warning, and the eat-even-when-you-do-not-want-to advice are all defensible and useful.

Where she oversimplifies: saying Ozempic "absolutely dries you out from the inside out" as a direct pharmacological effect is not quite accurate. Semaglutide does not cause dehydration as a primary mechanism. The dehydration risk comes from reduced fluid intake because you are eating and drinking less, and from GI side effects like nausea or diarrhea. The drug is not pulling water out of your tissues. That distinction matters for how people troubleshoot symptoms.

Her claim that weight loss comes from appetite suppression alone is also incomplete. Semaglutide acts on GLP-1 receptors in the brain, gut, and pancreas, affecting insulin secretion, glucagon suppression, and satiety signaling. Framing it as simply "you're just not thinking about food" undersells the complexity and could lead someone to believe willpower alone is doing the work, which is not what the evidence shows.

The alcohol swab recommendation is fine for hygiene but not universally required for subcutaneous insulin-type injections at home. The American Diabetes Association has moved away from requiring swabbing for clean skin in home settings, though it is not harmful.

What should you actually know?

If you are on semaglutide or considering it, the practical advice here is mostly sound. Drink water. Do not skip meals, especially protein. Do not reuse pen needles. Set a reminder for your injection day. None of those will hurt you and most will help.

But a few things @_sav_23 did not mention are worth knowing. Muscle loss is a documented concern on GLP-1 medications, and protein intake combined with resistance exercise is the best evidence-based counter to it (Bikou et al., 2023, Nutrients). If you are losing weight quickly and not strength training, you may be losing more muscle than fat.

Also, semaglutide is a prescription medication approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy) at specific doses. A TikTok series is not a substitute for working with a licensed prescriber who knows your full health picture. Her advice is not dangerous, but it is also not personalized. Use it as a starting point for questions to ask your provider, not as a protocol to follow.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Sav · TikTok creator

1.8M views on this video

1 year Ozempic experience, Part 3 Dos and Donts #ozempic

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about wilding et al. (2021, nejm) found participants on semaglutide lost?

Wilding et al. (2021, NEJM) found participants on semaglutide lost an average of 14.9% body weight over 68 weeks, with lean mass loss documented alongside fat loss.

What does the video say about pen needles?

Pen needles are single-use medical devices. Frid et al. (2016) confirmed reuse causes tip deformation that increases injection pain and local skin trauma.

What does the video say about semaglutide does not pharmacologically pull water from tissues. dehydration risk?

Semaglutide does not pharmacologically pull water from tissues. Dehydration risk comes from lower food and fluid intake and GI side effects like nausea, not a direct drying mechanism.

What does the video say about armstrong (2005, nutrition reviews) confirmed urine color?

Armstrong (2005, Nutrition Reviews) confirmed urine color and odor are reliable early markers of dehydration, supporting the creator's practical observation about strong-smelling urine.

What does the video say about bikou et al. (2023, nutrients) found resistance training combined with?

Bikou et al. (2023, Nutrients) found resistance training combined with adequate protein intake during GLP-1 therapy helps preserve lean muscle mass that would otherwise be lost.

What does the video say about the american diabetes association has moved away from requiring alcohol?

The American Diabetes Association has moved away from requiring alcohol swabbing before subcutaneous injections in home settings for patients with clean skin, though the practice is not harmful.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Sav, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.